신이식 후 호전을 보인 Nephrogenic Fibrosing Dermopathy = Nephrogenic Fibrosing Dermopathy Improved after Renal Transplantation

다국어 초록 (Multilingual Abstract)

Nephrogenic fibrosing dermopathy (NFD) is a rare cutaneous fibrosing disorder that primarily affects patients with a history of renal disease. NFD manifests with induration, thickening and hardening of the skin with brawny hyperpigmentation. Lesions are typically symmetrical and usually develop on the limbs and trunk. Flexion contractures of the joints may be a feature of the disease. Histopathological features of NFD include proliferation of dermal fibroblasts and dendritic cells, thickened collagen bundles, increased elastic fibers and focal mucin deposition. Although the pathogenesis remains largely unknown, some of the factors implicated in the pathogenesis include renal dysfunction, circulating fibrocytes, vascular injury, and gadolinium which is a contrast material used in magnetic resonance imaging. Currently, no definitive or uniformly effective therapies are available for the treatment of NFD. We herein describe the case of a 44-year-old female NFD patient who undergoes significant improvement of skin lesions and associated joint contracture after renal transplantation. (Korean J Dermatol 2010;48(2):143∼147)

참고문헌 (Reference)

1 Kafi R, "UV-A1 phototherapy improves nephrogenic fibrosing dermopathy" 140 : 1322-1324, 2004

2 Schmook T, "Successful treatment of nephrogenic fibrosing dermopathy in a kidney transplant recipient with photodynamic therapy" 20 : 220-222, 2005

3 Cowper SE, "Scleromyxoedemalike cutaneous diseases in renal-dialysis patients" 356 : 1000-1001, 2000

4 Lim YL, "Possible role of gadolinium in nephrogenic systemic fibrosis:report of two cases and review of the literature" 32 : 353-358, 2007

5 Cowper SE, "Nephrogenic fibrosing dermopathy:the first 6 years" 15 : 785-790, 2003

6 Sundararaman S, "Nephrogenic fibrosing dermopathy:lessons from the past" 45 : 639-641, 2006

7 Swartz RD, "Nephrogenic fibrosing dermopathy:a novel cutaneous fibrosing disorder in patients with renal failure" 114 : 563-572, 2003

8 Daram SR, "Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis:report of a new case with literature review" 46 : 754-759, 2005

9 Noah S, "Nephrogenic fibrosing dermopathy.A comprehensive review for the dermatologist" 7 : 237-247, 2006

10 Mackay-Wiggan JM, "Nephrogenic fibrosing dermopathy(scleromyxedema-like illness of renal disease)" 48 : 55-60, 2003

11 Ting WW, "Nephrogenic fibrosing dermopathy with systemic involvement" 139 : 903-906, 2003

12 Lauchli S, "Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis" 208 : 278-280, 2004

13 Cowper SE, "Nephrogenic fibrosing dermopathy" 23 : 383-393, 2001

14 Perazella MA, "Nephro genic fibrosing dermopathy:an unusual skin condition associated with kidney disease" 16 : 276-280, 2003

15 Grobner T, "Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?" 21 : 1104-1108, 2006

16 Quan TE, "Circulating fibrocytes:collagen-secreting cells of the peripheral blood" 36 : 598-606, 2004